Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

Tue, 13th Feb 2024 12:06

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

The pound traded higher, meanwhile, on robust labour market data which may encourage some to rethink their dovish Bank of England expectations.

The FTSE 100 index traded 20.66 points lower, 0.3%, at 7,553.03. The FTSE 250 was down 117.64 points, 0.6%, at 19,086.29, though the AIM All-Share edged down 0.14 of a point to 750.04.

The Cboe UK 100 fell 0.3% to 755.04, the Cboe UK 250 dropped 0.6% to 16,516.30, and the Cboe Small Companies was down 0.2% at 14,361.50.

The CAC 40 in Paris and the DAX 40 in Frankfurt were both down 0.5%.

Stocks in New York are called to open lower. The Dow Jones Industrial Average is called down 0.1%, the S&P 500 0.4% lower and the Nasdaq Composite down 0.7%.

"Markets remained in a holding pattern, awaiting the next wave of inflation, manufacturing and GDP data to see if it is possible to second guess when central banks might press the magic 'cut' button on interest rates," AJ Bell analyst Russ Mould commented.

"Stronger than expected labour data from the UK didn't help matters as it effectively gives the Bank of England another reason to keep rates steady and not rush to cut them."

The pound was quoted at USD1.2664 early Tuesday afternoon, up from USD1.2621, where it stood at the time of the London equities close on Monday.

According to the Office for National Statistics, the jobless rate faded to 3.8% in the three months to the end of December from 4.2% in the period from September to November.

Unemployment had been expected to ease slightly less, to 4.0%, according to FXStreet-cited market consensus.

Annual growth in regular earnings, so excluding bonuses, amounted to 6.2% in the three months to December. Including bonuses, earnings rose 5.8% on-year.

Pay growth was hotter than expected by both measures. Earnings including bonuses had been expected to rise by 5.6%, according to FXStreet, while excluding bonuses, a rise of 6.0% was forecast.

The next batch of UK unemployment data is scheduled for March 12, so before the BoE's next decision on March 21.

On Wednesday, the ONS reports UK inflation data for January. Annual consumer price inflation is expected to have picked up to 4.2% last month from 4.0% in December, according to FXStreet.

Analysts at Lloyds Bank commented: "Nevertheless, we expect inflation to resume its downtrend in February and to return to 2% by the spring. BoE policymakers, however, may want to see more evidence of a sustained fall in inflation to target before commencing with rate cuts."

The euro traded at USD1.0775 early Tuesday afternoon, largely flat against USD1.0769 late Monday. Versus the yen, the dollar bought JPY149.41, down slightly from JPY149.44.

The afternoon's main event will be the US inflation data at 1330 GMT. Annual consumer price growth is expected to have ebbed to 2.9% last month, according to FXStreet, from 3.4% in December.

Scope Markets analyst Joshua Mahony commented: "Coming off the back of a period that has seen the Federal Reserve consistently reigning in market expectations over the timing and scope of their 2024 rate cuts, today's expected slide in US CPI could be a short reprieve from that trend. With the 0.5% reading from last January dropping out of the annual metric, base effects should help provide the basis for a welcome decline in inflation today. However, the wider picture remains problematic, with the pathway back to 2% looking far from simple."

In London, property firms were among the worst large-cap performers following the red-hot UK data.

Property portal Rightmove fell 3.0%, while housebuilders Taylor Wimpey and Persimmon fell 2.1% and 1.7%.

Pharmaceutical firms traded higher, however, AstraZeneca rose 0.8% and GSK added 1.1%. Supporting the latter, Citi lifted the stock 'buy', its first positive rating on the shares in seven years.

Tui shares rose 1.7%. Tui's pretax loss narrowed to EUR103.1 million in the first quarter that ended December 31 from EUR272.6 million a year before, as revenue rose by 15% to a "record" EUR4.30 billion from EUR3.75 billion.

Underlying earnings before interest and tax were EUR6.0 million, swung from a EUR153.0 million Ebit loss a year before.

Edison analyst Russell Pointon commented: "Tui has unveiled its Q1 2024 results, showcasing a record-breaking performance.

"However, among the positive financial results, Tui's shareholders are poised to vote on the company's plans to delist from the London Stock Exchange, a move supported by the board but subject to shareholder approval at today's upcoming AGM. With market attention poised to quickly shift from Tui's results to its listing status, all eyes are on this pivotal moment in the company's trajectory."

Brent oil was quoted at USD82.55 a barrel midday Tuesday, rising from USD81.69 late Monday. Gold rose to USD2,027.59 an ounce from USD2,013.55.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.